Stay updated on Nivolumab Ramucirumab Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ramucirumab Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ramucirumab Combo in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision update from v3.3.3 to v3.3.4 with no changes to the study content, endpoints, eligibility criteria, or contact details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:24:38.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Locations section updated to list study sites in New York and Pennsylvania under a single Locations section, consolidating the prior 'New York Locations' and 'Pennsylvania Locations' entries.
    Difference
    0.3%
    Check dated 2025-12-23T09:46:23.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page revision label updated from v3.2.0 to v3.3.2 as part of a maintenance update. No changes to the study details, eligibility criteria, or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T18:56:11.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Removal of the government funding status notice; this does not affect the study details, endpoints, or other substantive content on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:08:27.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The two screenshots show the same ClinicalTrials.gov study record with no new or removed content in key sections such as the title, eligibility criteria, interventions, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T12:48:14.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    3%
    Check dated 2025-10-05T17:42:53.000Z thumbnail image

Stay in the know with updates to Nivolumab Ramucirumab Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ramucirumab Combo in NSCLC Clinical Trial page.